LABORATORY NEWS
-
Proscia Launches Fifth Generation Of Concentriq, Bringing The Latest Advancements In AI To Pathologists And Scientists
Proscia today introduced the Fifth Generation of its Concentriq[1] platform, helping pathologists focus on high-judgment decisions and enabling scientists to quickly move from early signals to evidence-based program decisions. Proscia is trusted by diagnostic laboratories that manage 12 million patient cases annually, and 16 of the top 20 pharmaceutical companies.
- Sysmex launches HISCL Platform, Enabling Faster, Scalable Alzheimer's Blood Testing
- KAUST Researchers Develop Technology That Could Make Cancer Diagnosis Faster
- Behemoth Labz Introduces Insights Into Growing Demand For COA Tested SARMs And Peptides In Research Applications
- Guardant Health Announces FDA Approval Of Guardant360 CDx As Companion Diagnostic For Boehringer Ingelheim's HERNEXEOS
ARCHIVED NEWSLETTER
- 05.26.26 -- Engineering Repeat-Dose RNA: Engineering Around Immune Recognition In Repeat-Dose RNA Therapeutics
- 04.21.26 -- Proteomics Tools: A Resurrection
- 04.07.26 -- Navigating GMP Biosafety Challenges In ATMP Manufacturing
- 02.24.26 -- Rethinking Disease Modification Through Targeted Immunotherapy
- 02.10.26 -- Why Use Total Organic Carbon Analysis For Cleaning Validation?